Fingerprint
Dive into the research topics of 'A randomized comparison of cyclophosphamide, DTIC with or without piperazinedione in metastatic malignant melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A randomized comparison of cyclophosphamide, DTIC with or without piperazinedione in metastatic malignant melanoma
MICHAEL TRONER, MD AND THE SOUTHEASTERN CANCER STUDY GROUP
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations